DIGESTIVE CANCER
Clinical trials for DIGESTIVE CANCER explained in plain language.
Never miss a new study
Get alerted when new DIGESTIVE CANCER trials appear
Sign up with your email to follow new studies for DIGESTIVE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for tough bile duct cancer
Disease control CompletedThis study tested a combination of the targeted drug regorafenib with chemotherapy (mGEMOX) in 66 people with advanced bile duct cancer that could not be removed by surgery. The main goal was to find the safest dose and check for side effects. This is not a cure, but aims to cont…
Matched conditions: DIGESTIVE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New Antibody-Drug combo targets Hard-to-Treat digestive cancers
Disease control CompletedThis phase 2 trial tested a drug called RC108 in 29 people with advanced digestive system cancers that have a protein called c-Met. RC108 is an antibody-drug combination given through a vein. The study looked at how well the drug shrinks tumors and what side effects occur. Result…
Matched conditions: DIGESTIVE CANCER
Phase: PHASE2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Foot massage may ease chemo sickness in cancer patients
Symptom relief CompletedThis study looked at whether foot reflexology—a type of foot massage—can reduce nausea and vomiting caused by platinum-based chemotherapy. Eighty people with lung or digestive cancer received reflexology sessions during their chemo infusions and were asked to do self-massage betw…
Matched conditions: DIGESTIVE CANCER
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Patient symptom surveys could cut chemo drug waste
Knowledge-focused CompletedThis study tested whether a 34-question symptom survey filled out by patients could give doctors enough information to authorize chemotherapy preparation, potentially reducing the number of unused drug doses. 138 people with digestive cancer participated. The goal was to see if t…
Matched conditions: DIGESTIVE CANCER
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC